Thaler, S.; Schmidt, M.; Thiede, G. et al.
Proteasome inhibitors prevent bi-directional HER2/estrogen-receptor cross-talk leading to cell death in endocrine and lapatinib-resistant HER2+/ER+ breast cancer cellsCANCER RESEARCH. Bd. 77. 2017
Thaler, Sonja; Schmidt, Marcus; Rosswag, Sven et al.
Proteasome inhibitors prevent bi-directional HER2/estrogenreceptor cross-talk leading to cell death in endocrine and lapatinib-resistant HER2+/ER+ breast cancer cellsONCOTARGET. Bd. 8. H. 42. 2017 S. 72281-72301
Ackermann, Maximilian; Mentzer, Steven J.; Roth, Wilfried et al.
Pulmonary microvascular architecture in hereditary haemorrhagic telangiectasiaTHORAX. Bd. 72. H. 9. 2017 S. 861-863
Wessler, Ignaz
Royal jelly of honeybees and pluripotent stem cells of mammals: two examples for non-neuronal acetylcholine (ACh) and the non-neuronal cholinergic systemJOURNAL OF NEUROCHEMISTRY. Bd. 142. 2017 S. 205-205
Mueller, Johannes; Raisi, Hanna; Rausch, Vanessa et al.
Sensitive and non-invasive assessment of hepatocellular iron using a novel room-temperature susceptometerJOURNAL OF HEPATOLOGY. Bd. 67. H. 3. 2017 S. 535-542
Ma, Bin; Dohle, Eva; Li, Ming et al.
TLR4 stimulation by LPS enhances angiogenesis in a co-culture system consisting of primary human osteoblasts and outgrowth endothelial cellsJOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE. Bd. 11. H. 6. 2017 S. 1779-1791
Hanke, Laura Isabel; Bartsch, Fabian; Foersch, Sebastian et al.
Transanal total mesorectal excision for restorative coloproctectomy in an obese high-risk patient with colitis-associated carcinomaMINIMALLY INVASIVE THERAPY & ALLIED TECHNOLOGIES. Bd. 26. H. 3. 2017 S. 188-191
Engelbarts, M.; Schad, A.; Matthias, C.
Unusual dysphagia in IgG4-related diseaseHNO. Bd. 65. H. 8. 2017 S. 680-683
Huber, Yvonne; Gehrke, Nadine; Biedenbach, Jana et al.
Voluntary distance running prevents TNF-mediated liver injury in mice through alterations of the intrahepatic immune milieuCELL DEATH & DISEASE. Bd. 8. 2017
Abu-Tayeh, Hanan; Weidenfeld, Keren; Zhilin-Roth, Alisa et al.
'Normalizing' the malignant phenotype of luminal breast cancer cells via alpha(v) beta(3)-integrinCELL DEATH & DISEASE. Bd. 7. 2016